Free Trial

Verona Pharma (VRNA) Insider Trading & Ownership

Verona Pharma logo
$72.73 +0.47 (+0.65%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$72.72 -0.02 (-0.02%)
As of 05/2/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Verona Pharma (NASDAQ:VRNA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.80%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$188,928.00
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$12.01 M
Get VRNA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Verona Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VRNA Insider Buying and Selling by Quarter

Verona Pharma Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/29/2025Andrew FisherGeneral CounselSell26,072$8.98$234,126.56  
4/29/2025David ZaccardelliCEOSell90,360$8.98$811,432.80  
4/29/2025Kathleen A RickardInsiderSell34,384$8.98$308,768.32  
4/29/2025Vikas SinhaDirectorSell20,000$8.92$178,400.00  
3/12/2025Kathleen A RickardInsiderSell79,264$8.35$661,854.40  
12/6/2024David ZaccardelliCEOSell162,800$5.01$815,628.00  
12/6/2024Mark W HahnCFOSell183,728$5.01$920,477.28  
12/4/2024David ZaccardelliCEOSell67,608$5.00$338,040.00  
12/4/2024Mark W HahnCFOSell58,184$5.00$290,920.00  
12/2/2024David ZaccardelliCEOSell3,200$5.00$16,000.00  
12/2/2024Mark W HahnCFOSell1,600$5.00$8,000.00  
11/29/2024David ZaccardelliCEOSell98,888$5.01$495,428.88  
11/29/2024Mark W HahnCFOSell98,704$5.01$494,507.04  
11/27/2024David ZaccardelliCEOSell23,240$5.00$116,200.00  
11/27/2024Mark W HahnCFOSell12,936$5.00$64,680.00  
11/25/2024Kathleen A RickardInsiderSell240,000$4.90$1,176,000.00  
11/25/2024Mark W HahnCFOSell1,600$5.00$8,000.00  
11/11/2024David ZaccardelliCEOSell2,400$5.00$12,000.00  
11/6/2024David R EbsworthDirectorBuy39,360$4.80$188,928.00  
11/4/2024David ZaccardelliCEOSell94,144$4.39$413,292.16  
11/4/2024Mark W HahnCFOSell80,784$4.39$354,641.76  
11/1/2024David ZaccardelliCEOSell46,888$4.38$205,369.44  
11/1/2024Mark W HahnCFOSell48,888$4.38$214,129.44  
10/25/2024David ZaccardelliCEOSell4,800$4.38$21,024.00  
10/24/2024Mark W HahnCFOSell141,360$4.38$619,156.80  
10/23/2024David ZaccardelliCEOSell16$4.38$70.08  
10/21/2024David ZaccardelliCEOSell110,456$4.38$483,797.28  
10/21/2024Mark W HahnCFOSell116,696$4.38$511,128.48  
10/18/2024David ZaccardelliCEOSell245,784$4.38$1,076,533.92  
10/18/2024Mark W HahnCFOSell249,728$4.38$1,093,808.64  
5/3/2024Kathleen A RickardInsiderSell36,248$1.96$71,046.08  
(Data available from 1/1/2013 forward)

VRNA Insider Trading Activity - Frequently Asked Questions

4.80% of Verona Pharma stock is owned by insiders. Learn more on VRNA's insider holdings.

The following insiders have purchased VRNA shares in the last 24 months: David R Ebsworth ($505,728.00), and Martin Edwards ($62,074.24).

Insiders have purchased a total of 233,096 VRNA shares in the last 24 months for a total of $567,802.24 bought.

The following insiders have sold VRNA shares in the last 24 months: Andrew Fisher ($234,126.56), Claire Poll ($105,948.40), David Zaccardelli ($5,391,991.44), Kathleen A Rickard ($2,592,539.92), Mark W Hahn ($5,161,250.24), Orbimed Advisors Llc ($9,003,837.04), and Vikas Sinha ($178,400.00).

Insiders have sold a total of 3,476,177 Verona Pharma shares in the last 24 months for a total of $22,668,093.60 sold.

Verona Pharma Key Executives



This page (NASDAQ:VRNA) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners